Literature DB >> 16246790

Elevated intraocular pressure in secondary piggyback intraocular lens implantation.

Takeshi Iwase1, Nobushige Tanaka.   

Abstract

We report 2 cases of postoperative intraocular pressure (IOP) elevation in secondary piggyback intraocular lens (IOL) implantation without history of glaucoma or ocular hypertension. A 74-year-old woman with myopic pseudophakia and a 68-year-old man with hyperopic pseudophakia received secondary piggyback AcrySof IOL implantation in their left eyes. In both patients, the left IOP gradually increased and sustained around 30 mm Hg for about 1 year. In the first, IOP continued elevating despite topical and systemic medications. There was an episode of pupillary block in the second. Gonioscopically, heavier trabecular meshwork pigmentation in their left eyes was observed. Because of this, the 2 IOLs implanted were removed and replaced by an adequate IOL and trabeculotomy was performed in the former. The AcrySof IOL has a truncated optic edge, which increases the risk for chafing the iris, resulting in pigment dispersion syndrome; thus, it would be a poor choice for a sulcus-placed piggyback implantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246790     DOI: 10.1016/j.jcrs.2005.06.034

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  14 in total

1.  Corrective Techniques and Future Directions for Treatment of Residual Refractive Error Following Cataract Surgery.

Authors:  Majid Moshirfar; Michael V McCaughey; Luis Santiago-Caban
Journal:  Expert Rev Ophthalmol       Date:  2014-12

2.  Assessment of a new hydrophilic acrylic supplementary IOL for sulcus fixation in pseudophakic cadaver eyes.

Authors:  N Reiter; L Werner; J Guan; J Li; K T Tsaousis; N Mamalis; S Srinivasan
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

3.  Pathologic assessment of complications with asymmetric or sulcus fixation of square-edged hydrophobic acrylic intraocular lenses.

Authors:  Kevin R Kirk; Liliana Werner; Ryan Jaber; Susan Strenk; Lawrence Strenk; Nick Mamalis
Journal:  Ophthalmology       Date:  2012-03-15       Impact factor: 12.079

4.  Stability and safety of MA50 intraocular lens placed in the sulcus.

Authors:  P S Kemp; T A Oetting
Journal:  Eye (Lond)       Date:  2015-07-03       Impact factor: 3.775

5.  Pathologic comparison of asymmetric or sulcus fixation of 3-piece intraocular lenses with square versus round anterior optic edges.

Authors:  Andrew Ollerton; Liliana Werner; Susan Strenk; Lawrence Strenk; Lisa Leishman; Zachary Bodnar; Kevin R Kirk; Jennifer Michelson; Nick Mamalis
Journal:  Ophthalmology       Date:  2013-04-16       Impact factor: 12.079

6.  Long-term results of clear lens extraction combined with piggyback intraocular lens implantation to correct high hyperopia.

Authors:  Xia Hua; Xiao-Yong Yuan; Hui Song; Xin Tang
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

7.  [Refractive long-term results after piggyback intraocular lens implantation].

Authors:  B Moustafa; H Häberle; C Wirbelauer; D T Pham
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

8.  Novel observations and potential applications using digital infrared iris imaging.

Authors:  Daniel K Roberts; Ana S Lukic; Yongyi Yang; Sayoko E Moroi; Jacob T Wilensky; Miles N Wernick
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2009 Mar-Apr

9.  Outcomes of toric supplementary intraocular lenses for residual astigmatic refractive error in pseudophakic eyes.

Authors:  Cameron A McLintock; James McKelvie; Zisis Gatzioufas; Jessica J Wilson; David C Stephensen; Andrew J G Apel
Journal:  Int Ophthalmol       Date:  2018-10-29       Impact factor: 2.031

10.  Late-onset secondary pigmentary glaucoma following foldable intraocular lenses implantation in the ciliary sulcus: a long-term follow-up study.

Authors:  Shirley Hl Chang; Wei-Chi Wu; Shiu-Chen Wu
Journal:  BMC Ophthalmol       Date:  2013-06-07       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.